NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and should even be effective against new strains ...

U.S. Antiviral Drugs Market to Surpass USD 27.07 Billion by 2032, Fueled by Chronic Infection Treatment Demand and Strong R&D Ecosystem.Austin, July 17, 2025 (GLOBE NEWSWIRE) -- Antiviral Drugs Market ...

A group of researchers says delayed treatment of a type of bird flu now spreading on dairy farms in the United States may ...

The first and most widely used single-dose antiviral flu pill is baloxavir marboxil, marketed as Xofluza and developed by the ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu prevention.

The Department of Public Health and Social Services encourages proactive approach to protect oneself and others from health ...

Severe fever with thrombocytopenia syndrome (SFTS) was reported in Asia, with a fatality rate that can reach as high as 50%.

Background The large-scale deployment of antiviral drugs from the Strategic National Stockpile during the 2009 H1N1 influenza response provides a unique opportunity to study local public health ...

A new long-acting influenza drug by Cidara Therapeutics demonstrated up to 76% protection against symptomatic flu in a phase ...